These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling. Al-Najjar BO, Wahab HA, Tengku Muhammad TS, Shu-Chien AC, Ahmad Noruddin NA, Taha MO. Eur J Med Chem; 2011 Jun 27; 46(6):2513-29. PubMed ID: 21482446 [Abstract] [Full Text] [Related]
6. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits. Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G. J Mol Graph Model; 2010 Jan 27; 28(5):383-400. PubMed ID: 19850503 [Abstract] [Full Text] [Related]
8. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO. Eur J Med Chem; 2010 Apr 27; 45(4):1598-617. PubMed ID: 20116902 [Abstract] [Full Text] [Related]
10. Discovery of new β-D-galactosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening. Abdula AM, Khalaf RA, Mubarak MS, Taha MO. J Comput Chem; 2011 Feb 27; 32(3):463-82. PubMed ID: 20730780 [Abstract] [Full Text] [Related]
12. Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation. Al-Sha'er MA, Mansi I, Khanfar M, Abudayyh A. J Enzyme Inhib Med Chem; 2016 Feb 27; 31(sup4):64-77. PubMed ID: 27569779 [Abstract] [Full Text] [Related]
13. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation. Al-Nadaf AH, Taha MO. J Mol Graph Model; 2011 Apr 27; 29(6):843-64. PubMed ID: 21376648 [Abstract] [Full Text] [Related]
18. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening. Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N. J Mol Graph Model; 2007 Mar 27; 25(6):870-84. PubMed ID: 17035054 [Abstract] [Full Text] [Related]
19. Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors. Abuhamdah S, Habash M, Taha MO. J Comput Aided Mol Des; 2013 Dec 27; 27(12):1075-92. PubMed ID: 24338032 [Abstract] [Full Text] [Related]
20. Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin. Taha MO, Bustanji Y, Al-Ghussein MA, Mohammad M, Zalloum H, Al-Masri IM, Atallah N. J Med Chem; 2008 Apr 10; 51(7):2062-77. PubMed ID: 18324764 [Abstract] [Full Text] [Related] Page: [Next] [New Search]